Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 5 e, j, o
Cervino AS et al. (2023)
|
Xla WT + ssbp2 MO
NF32 (in situ hybridization)
|
|
|
|
Fig S5. e j o p
Cervino AS et al. (2023)
|
Xla WT + ssbp2 MO
NF32 (in situ hybridization)
|
|
|
|
Fig. 4 e f i
Cervino AS et al. (2023)
|
Xla WT + ssbp2 MO
NF37/38 (immunohistochemistry)
|
|
|
|
Fig. 6. f f' g
Cervino AS et al. (2023)
|
Xla WT + ssbp2 MO
NF37/38 (immunohistochemistry)
|
|
|
|
Fig. 6. m o
Cervino AS et al. (2023)
|
Xla WT + ssbp2 MO
NF42 (immunohistochemistry)
|
|
|